Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
NAV as on 08-04-2025
₹ 18.47
1D
Inception Returns
14.6%
/yr
Historical NAV & Returns
Absolute
▲
▼
5396 people have invested ₹ 45.7L in Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth in the last three months
About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is an equity fund. This fund was started on 26 October, 2020. The fund is managed by Bhavesh Jain. The fund could potentially beat inflation in the long-run.
Key Parameters
- Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has ₹152 Cr worth of assets under management (AUM) as on Feb 2025 and is less than category average.
- The fund has an expense ratio 0.5.
Returns
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has given a CAGR return of 14.62% since inception. Over the last 1 and 3 years the fund has given a CAGR return of 4.92% and 12.68% respectively.
Holdings
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health. Its top holdings are Sun Pharmaceuticals Industries Ltd, Eli Lilly and Co, Max Healthcare Institute Ltd Ordinary Shares, Cipla Ltd, Divi's Laboratories Ltd
Taxation
As it is a index funds mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
Investment objective of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
The Scheme will invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 100.00 and for SIP is INR 100.00. Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has no lock in period.
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth Overview
| Expense ratio | 0.5% |
Benchmark | MSCI Ind Dom & Wld HealthC 45 NR INR |
| AUM | ₹152 Cr |
| Inception Date | 26 October, 2020 |
| Min Lumpsum/SIP | ₹100/₹100 |
| Exit Load | 0% |
| Lock In | No Lock-in |
TurnOver | 7.8% |
| STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
Fund Distribution
as on (28-Feb-25)
Large cap
32.1%
Mid cap
28.5%
Small cap
5.8%
Sector Allocation
Health
100%
All changes are between Dec'24 and Feb'25
- AUM of the fund stands at 152 Cr as of Feb'25
- AUM decreased by 0.8 Cr between Feb'25 and Jan'25
Top Stocks bought last month
Eli Lilly and Co's allocation increased from 5.61% to 6.34%
AbbVie Inc's allocation increased from 2.78% to 3.16%
Johnson & Johnson's allocation increased from 3.13% to 3.39%
Top Stocks sold last month
Sun Pharmaceuticals Industries Ltd's allocation decreased from 12.37 % to 11.92 %
Max Healthcare Institute Ltd Ordinary Shares's allocation decreased from 6.1 % to 5.93 %
Dr Reddy's Laboratories Ltd's allocation decreased from 5.92 % to 5.08 %
Large Cap allocation has gone down from 32.6% to 32.1%
Small Cap allocation has gone up from 5.7% to 5.8%
Mid Cap allocation has gone down from 29.2% to 28.5%
Cash allocation has gone down from 0.3% to -0.1%
Top Sector in February was Health
Feb'25
Health
100%
Jan'25
Health
100%
Holdings | Weight% | 1M Change | |
|---|---|---|---|
 Sun Pharmaceuticals Industries Ltd | 11.92% | 4.9% | |
 Eli Lilly and Co | 6.34% | -1.7% | |
 Max Healthcare Institute Ltd Ordinary Shares | 5.93% | 4.8% | |
 Cipla Ltd | 5.76% | 4.9% | |
 Divi's Laboratories Ltd | 5.1% | 4.9% |
See all
Funds | 1Y Returns | 3Y Returns | 5Y Returns | Since Inception |
|---|---|---|---|---|
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 4.92% | 12.68% | - | 14.62% |
 Motilal Oswal Nifty Bank Index Fund Direct Growth | 4.62% | 10.87% | 21.78% | 11.75% |
Motilal Oswal Nifty 500 Fund Direct Growth | -1.06% | 10.79% | 23.89% | 16.62% |
 Aditya Birla Sun Life Nifty Smallcap 50 Index Fund Direct Growth | -1.88% | 13.85% | - | 15.7% |
See all
Top Growth Drivers | 1M Return |
|---|---|
 Max Healthcare Institute Ltd | 11.5% |
 Apollo Hospitals Enterprise Ltd | 8.7% |
 Sun Pharmaceutical Industries Ltd | 3.4% |
Loading...
We are taking more time than usual
Bhavesh Jain
Fund Manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth, since 1 October 2021
Top funds managed
Fund House
Edelweiss Asset Management Limited
Total Schemes
Total AUM
₹1.07L Cr
as on 28-Feb-2025
Address
Edelweiss House, Off C.S.T. Road, Kalina
Phone
91-22-40979900
Website
investor.amc@edelcap.com
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 14.62% since inception which is more than its category average return of 5.45%
Fund Allocations
This fund has an allocation of 100.13% in Equity, 0% in Debt and -0.13% in Cash related instruments
AUM size ₹152 Cr
This fund has AUM of ₹152 Cr which is less than its category average of ₹ 734 Cr
Expense Ratio 0.5%
This fund has an expense ratio of 0.5% which is less than its category average expense ratio of 0.54%
More funds from Edelweiss
5Y CAGR
▲ 34.60
5Y CAGR
▲ 36.35
5Y CAGR
▲ 26.18
5Y CAGR
▲ 25.97
Frequently Asked Questions for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
The current NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is ₹18.47 as on 08-Apr-2025.
Existing (Absolute + CAGR) as on 08-Apr-2025.
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | -4.71% | -4.71% |
6 Month Returns | -9.49% | -9.49% |
1 Year Returns | 4.92% | 4.92% |
3 Years Returns | 43.08% | 12.68% |
5 Years Returns | 0% | 0% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
0.5% as on March 2025
₹152 Cr as on March 2025
Sun Pharmaceuticals Industries Ltd(11.92%), Eli Lilly and Co(6.34%), Max Healthcare Institute Ltd Ordinary Shares(5.93%), Cipla Ltd(5.76%), Divi's Laboratories Ltd(5.1%) as on March 2025
The alpha ratio for the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | - | - | - |
As on March 2025
The alpha for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is calculated against MSCI Ind Dom & Wld HealthC 45 NR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | - | - | - |
As on March 2025
The Beta for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is calculated with MSCI Ind Dom & Wld HealthC 45 NR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 0.39 | 0.71 | - |
As on March 2025
The sharpe ratio for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is calculated with MSCI Ind Dom & Wld HealthC 45 NR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 12.53 | 13.13 | - |
As on March 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.28 as on March 2025. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Bhavesh Jain is the fund manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth
The Exit load of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is 0%